Drug Discovery

This research service focuses on antiviral therapeutics for the treatment of the hepatitis C virus (HCV). A global product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HCV. Segmentation by drug class is provided, along with supporting information such as clinical trial t...

The CEO 360 Perspective presentation provides a holistic view of the 7 perspectives that affect C-level driven decisions, within the Drug Discovery Technologies markets. This includes the global, integrated industry, technology, economic, competitive, customer and best practices perspective. Each perspective provides insight into the current and f...

This research service analyzes optical technologies within the United States clinical imaging and drug discovery markets. The market is further divided into seven distinct sub-segments. Each segment covers key challenges, market trends, technology trends, competitive structure and revenue forecasts, with a base year of 2007.

The World Drug Discovery Technologies market is a dynamic marketplace with substantial opportunity. This study focuses on the market dynamics of 2005, by looking at the four major contributors to this market: top 20 pharmaceutical companies, biotechnology companies, top 5 agribiotech companies, and the NIH budget. The study also provides detailed ...

This research service provides a detailed overview and analysis of U.S. drug discovery contract research organization markets. The research service includes a detailed analysis of market drivers, restraints and trends. Industry challenges and corresponding strategies have also been provided. Revenue forecasts from 2007 to 2013 have also been inclu...